Modified DRPT better for detecting primary angle closure

Article

Conducting a modified dark room provocative test (DRPT) is better for the diagnosis of primary angle closure, compared to gonioscopic angle assessment.

Conducting a modified dark room provocative test (DRPT) is better for the diagnosis of primary angle closure, compared to gonioscopic angle assessment, reveals a study in the Journal of Glaucoma.

Dr Dejiao Li led a cross-sectional observational prospective clinical study on 76 eyes of 76 patients. The anterior chamber angle configuration was measured in a light room and then after three minutes of dark adaptation using anterior segment optical coherence tomography (AS-OCT).

In light room conditions at baseline and after 1.5 hours of dark adaptation gonioscopy and Perkin's applanation tonometry were performed. The DRPT was identified as positive if intraocular pressure (IOP) increased by ≥8 mmHg after 1.5 hours of dark adaptation.

There were a significant number of eyes with an increased number of closed angle quadrants for the OCT examination at 3 minutes of dark adaptation, compared to gonioscopy at 1.5 hours of dark adaptation. For AS-OCT the area under the receiver operator characteristics curve was significantly larger, compared to gonioscopy.

A modified DRPT in combination with an anterior chamber angle assessment by OCT at 3 minutes of dark adaptation demonstrated a higher diagnostic precision for primary angle closure.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.